Cal-Maine (CALM) Stock Trades Down, Here Is Why

Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.

Freshpet (FRPT) reported Q2 revenue of $305.6M, up 15.5% YoY, beating estimates. Cal-Maine (CALM) saw revenue drop 41.5% YoY to $539.6M, missing expectations. Pilgrim's Pride (PPC) reported $4.63B revenue, down 2.8% YoY, also missing estimates. United Natural Foods (UNFI) reported flat revenue at $7.64B, slightly missing expectations. All stocks except UNFI are down since reporting.

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.

Cal-Maine Foods reported Q1 2027 sales of $539.61M and a net loss of $58.62M, both down year-over-year. Lower demand and pricing for conventional shell eggs impacted profitability, leading to a suspended dividend. The company continued share repurchases and rolled out Amino to improve data flows, focusing on operational efficiency. Investors now assess the impact of these results on the company's investment narrative, with a P/E of 53x and execution risks highlighted.

Cal-Maine Foods (CALM) reported Q1 FY2027 earnings below estimates, with revenue down 41.5% YoY and a net loss of $58.6M. Management cited oversupply in the conventional egg market and rising costs. The stock fell 3.5% premarket. Next catalysts include Q2 earnings and prepared foods capacity expansion.